Insider Transactions in Q3 2025 at Kymera Therapeutics, Inc. (KYMR)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 17
2025
|
Bruce N. Jacobs Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
79,220
-25.84%
|
$3,961,000
$50.0 P/Share
|
|
Sep 17
2025
|
Bruce N. Jacobs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
79,220
+20.53%
|
$158,440
$2.08 P/Share
|
|
Sep 16
2025
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,000
-4.34%
|
$1,470,000
$49.0 P/Share
|
|
Sep 16
2025
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+4.16%
|
$60,000
$2.08 P/Share
|
|
Sep 03
2025
|
Brian Adams Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,500
+50.0%
|
-
|